Patrick Forde, MD
Enriched profilePrendergast Professor of Immuno-Oncology, Trinity College Dublin / Trinity St James's Cancer Institute; Consultant Medical Oncologist, St James's Hospital Dublin; Professor of Oncology, Johns Hopkins University School of Medicine · Trinity College Dublin
Patrick Forde is Prendergast Professor of Immuno-Oncology, Trinity College Dublin / Trinity St James's Cancer Institute; Consultant Medical Oncologist, St James's Hospital Dublin; Professor of Oncology, Johns Hopkins University School of Medicine at Trinity College Dublin. OpenAlex indexes 544 publications with 19,787 citations (h-index 66); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Patrick Forde, MD, is Prendergast Professor of Immuno-Oncology, Trinity College Dublin / Trinity St James's Cancer Institute. The public record shows 544 publications with 19,787 citations (h-index 66), centered on Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 27 companies.
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Cancer Immunotherapy and Biomarkers
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 161.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Industry payments
Updated 15 Oct 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments$13,035openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
64.1%Kinase inhibitor64.1%Tagrisso72%Xalkori28%Part D<11 patientsNervous system
20.5%Phenothiazine20.5%Prochlorperazine Maleate100%Part D<11 patientsGenitourinary & hormones
15.4%alpha-Adrenergic Blocker15.4%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 15 Oct 2026
100 congress contributions (2009–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract LB105: Translational analyses from the randomized phase 3 DREAM3R trial: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma
AACR Annual Meeting
AACR2026Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer.
Cancer research communications
Article2026 - How Much Is Enough? Ultra-Low Doses of Immunotherapy to Improve Access and Affordability.
Journal of clinical oncology
Editorial2026 - Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.
Nature medicine
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01Neoadjuvant PD-1 Blockade in Resectable Lung Cancer2,139 citations2018
- 02Genome-wide cell-free DNA fragmentation in patients with cancer1,483 citations2019
- 03
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/patrick-forde-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/patrick-forde-3aa7b745
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
people.tcd.ie/fordep1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →people.tcd.ie ↗ - Other
hopkinsmedicine.org/profiles/results/directory/profile/0554010/patrick-forde
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Other
tcd.ie/research/profiles
- ResearchGate
researchgate.net/scientific-contributions/Patrick-Forde-2188948300/publications/2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Patrick-M-Forde-2033496023
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/FordePatrick
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - X / Twitter
X / Twitter handle @FordePatrick
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBBCh (medical degree)
Royal College of Surgeons in Ireland
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesothelioma.net ↗ - Internal medicine residency and medical oncology fellowship
Royal College of Physicians of Ireland
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesothelioma.net ↗ - Medical oncology fellowship
Johns Hopkins University School of Medicine / Sidney Kimmel Comprehensive Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesothelioma.net ↗
Editorial & leadership roles
journal and society appointments- Principal Investigator
CheckMate 816 trial (neoadjuvant nivolumab plus chemotherapy in resectable NSCLC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nejm.org ↗ - Member
American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), Society for Immunotherapy of Cancer (SITC), American Association for Cancer Research (AACR) …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tcd.ie ↗
Awards & honors
honors on the public record- 2022 Daniel C. Ihde Lectureship Award for Medical Oncology
International Association for the Study of Lung Cancer (IASLC)
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mesothelioma.net ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mesothelioma.net ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncologyconferences.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mesothelioma.net ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mesothelioma.net ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗
Secondary affiliations
appointments beyond the home institution- St James's Hospital
Dublin (Consultant Medical Oncologist)
- Johns Hopkins University School of Medicine / Sidney Kimmel Comprehensive Cancer Center - Professor of Oncology; Co-Director
Division of Upper Aerodigestive Malignancies; Director …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗
Media & interviews
press, podcasts and appearances- Podcast: "Pre-Operative Immunotherapy Clinical Trial with Dr. Patrick Forde of Johns Hopkins"
Meet the Mesothelioma Experts podcast series, Mesothelioma Applied Research Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curemeso.org ↗ - Podcast: "PW PODCAST: CheckMate 816"
Physician's Weekly
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciansweekly.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncologynewscentral.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iaslc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Martina Hennessy
Trinity College Dublin
Alan D. Irvine
Trinity College Dublin
Gordon Blackshields
Trinity College Dublin
Cliona O’Farrelly
Trinity College Dublin
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center